Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients with myeloid neoplasms including MDS, MDS/MPN overlap syndromes and CMML
- Any patients not meeting the above mentioned disease criteria.
- Any patient who has declined participation in research activity.
- For quarterly samples if hemoglobin is <8 gm/dl and/or HCT < 30%